Itonis to Ship More Emesyl™ Nausea Relief to Hensley Brothers
Distribution, LLC
LAGUNA HILLS, CA - February 03, 2015 - InvestorsHub NewsWire -
Itonis, Inc. (OTC
PINKSHEETS: ITNS)
Itonis, Inc. announced today that Hensley Brothers Distribution,
LLC (an Itonis distributor) has requested additional shipments of
Emesyl™ Nausea Relief.
"We take this as an indicator of the market viability of the
product," said Mark Cheung, CEO of Itonis. He
added, "To receive this request is quite encouraging considering
the product had only recently entered the market."
Emesyl™ Nausea Relief first became available publicly on
Amazon.com for sale orders. (http://www.amazon.com/Itonis-Pharmaceuticals-EMESYL-Nausea-Relief/dp/B00SZ423XA/ref=sr_1_2?ie=UTF8&qid=1422946405&sr=8-2&keywords=emesyl)
Additionally, Hensley Brothers Distribution “has stepped
up [its] roll out of Emesyl™ Nausea Relief to retailers in Lodi,
California” as part of its efforts to place Emesyl™ Nausea Relief
“into national big box retail and the travel and tourist
distribution network,” said Steven Hensley, Vice-President of
Hensley Brothers Distribution. (http://www.accesswire.com/viewarticle.aspx?id=425483)
About Emesyl™
www.itonisholdings.com/emesyl
About Itonis Pharmaceuticals
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by
Charles Hensley, Ph.D., and its mission is to create and market
over-the-counter and prescription homeopathic products that better
people's lives. Dr. Hensley is a pioneer in the development and
marketing of safe and effective therapeutic nutraceutical and
homeopathic preparations. He was a founder of the company
that launched the Zicam® Cold Remedy, making the product a
household name and forever changing the marketing and product
placement paradigm for homeopathic drugs in the United
States. Dr. Hensley and his team plan to use the same
methodologies to revolutionize the treatment of several other
common ailments and other chronic diseases.
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis
Inc. has focused on transitioning itself in the past year from
acquiring high growth, market niche entrepreneurial companies, to a
market leader focused on the distribution of innovative products to
the medical and pharmaceutical industry. Please visit www.itonisholdings.com.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact:
Itonis, Inc.
Office@itonisholdings.com
